Skip to main content
All blogsResearch

Where to Inject Thymosin Alpha-1: Site Map

Thymosin Alpha-1 goes under the skin, 20 units at a time, five weekdays out of seven. That daily cadence changes how you should think about site selection and rotation. Here is the practical version: the four sites, the syringe math, the weekly map, and the one confusion worth clearing up before your first dose.

PeRx PeptidesReviewed by Dr. Cory Mellon, MD12 min readPublished
Where to Inject Thymosin Alpha-1: Site Map

Key Takeaways

  • Thymosin Alpha-1 is subcutaneous only. Four usable regions: the abdomen (staying two inches clear of the navel), the front or outer thigh, the upper outer glute, and the fat pad behind the deltoid.
  • The prescribed dose is 20 units on a U-100 insulin syringe, which works out to 0.2 mL, taken once daily Monday through Friday. Weekends off is built into the schedule.
  • No cycling is required. Ta1 is prescribed for continuous long-term use, which makes rotation discipline more important here than with a peptide you inject twice a week.
  • Tolerability is the headline. Reactions are rare, and the ones patients mention are mild soreness at the site and, occasionally, mild flu-like symptoms.
  • Thymosin Alpha-1 and TB-500 are unrelated molecules despite the shared family name. Ta1 is the only thymosin PeRx sells on its own; TB-500 appears only inside combination vials.

Thymosin Alpha-1 Injection Quick Facts

Route

Subcutaneous, under the skin (never into muscle)

Vial

5 mL at 5 mg/mL, ships ready to use

Dose

20 units (0.2 mL), once daily

Schedule

Monday through Friday, weekends off

Sites

Abdomen, thigh, upper outer glute, back of deltoid

Cycling

None required; continuous use as prescribed

Ta1 Goes Under the Skin

The answer to where to inject thymosin alpha-1 is any of four subcutaneous regions: the abdomen, the front or outer thigh, the upper outer glute, or the fat pad behind the deltoid. Under the skin, not into muscle. The dose is small, 20 units on an insulin syringe, and it repeats once a day from Monday through Friday. For the biology behind the molecule, where it comes from and what the clinical record actually shows, start with the thymosin alpha-1 guide. If you have never given yourself a subcutaneous shot at all, our walkthrough on injecting peptides covers the mechanics from hand-washing to sharps disposal. This page is the narrow version: sites, syringe math, a weekly rotation map, and the details that are specific to Ta1.

One thing to settle before you open the box. Your vial ships fully reconstituted and ready to use. There is no powder, no mixing step, and nothing to add. You uncap a syringe, draw to the 20-unit mark, and inject.

Where to Inject Thymosin Alpha-1: The Four Standard Sites

Every subcutaneous peptide uses the same four anatomical regions, and Ta1 is no exception. They differ in fat depth, in how easy they are to reach one-handed, and in how much usable surface area they give you for rotation.

1. Abdomen. Picture the band between your lowest ribs and your hip bones, minus a two-inch exclusion zone circling the navel. Most patients live here. The tissue is forgiving, you can see exactly what you are doing, and the surface area is large enough to keep rotating for weeks without repeating a spot. Work the soft area to the left and right of the belly button rather than the midline directly above or below it.

2. Front or outer thigh. The meaty middle third of the leg, on the front or the outside. Injecting the thigh while seated is easy to do one-handed, which is why it usually becomes site number two. Stay off the inner thigh, where vessels run closer to the surface, and leave a hand-width of clearance from both the knee and the hip crease.

3. Upper outer glute. The upper outer quadrant of the buttock, above and to the outside of where you would sit. Fat tends to be deepest here, so it is comfortable, but reaching it yourself takes a mirror or a willing partner. Patients on a five-day schedule often park one dose a week here purely to give the abdomen a rest day.

4. Back of the deltoid. The loose fat pad on the back of the upper arm, behind the deltoid muscle. This site depends entirely on your build. Pinch the area first: if you can gather half an inch of skin and fat, you have enough. If the skin snaps flat against muscle, pick a different region and stop thinking about this one.

Picking Your Primary Site

Nothing suggests that placing Ta1 in the thigh instead of the abdomen changes what the peptide does. It is absorbed into circulation from subcutaneous fat and reaches immune cells wherever they happen to be, so anatomy is a comfort question rather than a targeting one. Choose based on fat coverage, on how easily you can reach the spot, and on how much room the region gives you to rotate.

For most people that means the abdomen carries the bulk of the schedule, the thighs absorb two or three doses a week, and the glute comes in periodically. The deltoid is the one to skip unless you have genuine fat coverage there. Daily dosing rewards a plan you can actually keep track of, so pick two primary regions and one backup rather than trying to use all four evenly.

Practical Default

Abdomen and thigh as your two workhorses, glute as the periodic rest-day site, deltoid only if you can pinch a clear half inch of fat there.

The Dose and the Weekday Schedule

Thymosin Alpha-1 Protocol

Route

Subcutaneous injection

Vial

5 mL at 5 mg/mL

Dose

20 units (0.2 mL)

Frequency

Once daily, Monday through Friday

Cycling

None required

The units-versus-milliliters confusion trips up more first-time patients than site selection ever does. A U-100 insulin syringe is marked in units, and 100 of those units fill 1 mL. So the 20-unit line on the barrel is 0.2 mL of solution. You do not need to convert anything or do math at the counter. Draw to 20 and stop.

The arithmetic on the vial is worth knowing anyway. Five milliliters at 5 mg/mL holds 25 mg of peptide, and each 0.2 mL dose delivers 1 mg. That is 25 weekday doses per vial, or five working weeks. Read the barrel at eye level with the syringe upright rather than eyeballing it against the vial, because at this volume a small misread is a large fraction of the dose.

The Monday-through-Friday pattern is the prescribed schedule, not a workaround. Weekends off is already part of it. Ta1 requires no cycling and is intended for continuous long-term use as prescribed, so there is no washout week to plan for and no reason to interrupt the pattern on your own. Dose and frequency come from your prescription; nothing on this page replaces the label on your vial.

Building a Five-Day Rotation

Rotation matters more on a daily peptide than on one you inject twice a week, for the obvious reason: you are asking your tissue to absorb roughly twenty injections a month instead of eight. Hitting the same square inch repeatedly produces small firm nodules, occasional bruising, and thickened tissue that absorbs the next dose less predictably. None of that is dangerous. All of it is avoidable.

The working rule is a finger-width, about one inch, from wherever the last needle went. That is easy to satisfy inside a single region. Split the abdomen into quadrants on each side of the navel and you have eight distinct spots before you have to leave the area at all.

A five-day map that most patients can hold in their head: Monday upper right abdomen, Tuesday upper left abdomen, Wednesday right thigh, Thursday left thigh, Friday lower abdomen or glute. The following week, run the same order but shift each spot a finger-width from where it landed last time. Two weeks of that and no square inch has taken more than one needle.

Low-Tech Tracking

If you cannot remember Thursday by Friday, a fingernail indent next to the last spot or a dot on a phone note is enough. Tracking beats remembering, especially on a five-day-a-week schedule.

Ta1 Is Not TB-500

This is the single most common mix-up in the thymosin category, and it is worth ninety seconds of your time. Thymosin Alpha-1 and TB-500 share a family name and almost nothing else. They are different molecules from different branches of the thymosin family, they are used for different reasons, and they are not interchangeable at any dose.

What it is

Thymosin Alpha-1
A 28-amino-acid thymic peptide
TB-500 (Thymosin Beta-4)
A synthetic fragment of thymosin beta-4, a separate protein

Family

Thymosin Alpha-1
Alpha branch of the thymosins
TB-500 (Thymosin Beta-4)
Beta branch; a shared word, not a shared mechanism

Why patients use it

Thymosin Alpha-1
Immune support
TB-500 (Thymosin Beta-4)
Tissue repair and recovery support

How PeRx supplies it

Thymosin Alpha-1
Its own vial, the only thymosin sold on its own
TB-500 (Thymosin Beta-4)
Only inside combination vials, never standalone

Route

Thymosin Alpha-1
Subcutaneous
TB-500 (Thymosin Beta-4)
Subcutaneous

Injection sites

Thymosin Alpha-1
The same four regions
TB-500 (Thymosin Beta-4)
The same four regions

The practical upshot for anyone reading a protocol they found elsewhere: a dosing schedule written for TB-500 tells you nothing about Ta1. If you want the tissue-repair side of the catalog, that lives in the combination products, and the BPC-157 and TB-500 guide explains how those are put together. Ta1 stands alone, and it is the only thymosin that does.

Why Ta1 Is Easy to Tolerate

Tolerability is the quiet reason this peptide reads well on paper. Side effects are rare, which matters when the schedule asks you to inject five days a week for months at a stretch.

What does show up is minor. Mild discomfort at the injection site is the common one, and it is usually technique-driven: cold solution straight from the fridge, a fast plunger, or a needle that has already been through a stopper once. Rare mild flu-like symptoms have also been reported. Neither is a reason to stop on your own, and neither is what most patients experience.

Two habits cut site discomfort further. Let the syringe sit at room temperature for a minute or two after drawing rather than injecting straight-from-the-fridge solution, and push the plunger slowly enough that the injection takes several seconds rather than one. If you are weighing what is normal against what is not across peptides generally, the peptide side effects guide sorts the routine from the notable.

Storage, Handling, and Travel

PeRx ships Thymosin Alpha-1 fully reconstituted and ready to use. Store it refrigerated at 36-46°F (2-8°C), keep the vial upright, and do not freeze it. Put it back in the refrigerator right after you draw rather than leaving it on the counter through breakfast.

Look at the solution every single time before you draw. It should be clear. Particles, cloudiness, or a color shift all mean set it aside and contact your provider instead of injecting it. Since one vial covers five weeks of weekday dosing, you will be inspecting the same vial a lot of mornings, and that is exactly the situation where the habit slips.

Travel is straightforward. An insulated bag with a small ice pack handles anything longer than a couple of hours. Keep the vial in your carry-on, never in checked luggage, and bring the prescription label or a screenshot of your PeRx order in case anyone asks at security. A five-day-a-week schedule means most trips will overlap at least a few doses, so pack the syringes too.

Precautions and When to Call

Ta1 is an immune-modulating peptide, and that is the source of its one real precaution. Transplant recipients and anyone taking immunosuppressant medication need caution here, because deliberately nudging immune activity in someone whose treatment plan depends on suppressing it is a genuine conflict. Flag either situation during screening rather than after your first vial arrives.

Call 911

Swelling of the face, throat, or tongue, difficulty breathing, rapid heartbeat, severe dizziness, or a fever above 103°F / 39.4°C are emergencies. Call 911. Do not wait to see whether they settle down.

Short of that, the ordinary stuff is ordinary. Redness that fades within a day, a small bruise, mild tenderness at a spot you have used recently: all routine, all handled by moving an inch and slowing the plunger down. If a site stays firm or sore for more than a couple of days, stop using that region and rotate elsewhere while it settles. If it has not cleared after a few days, or if a mild rash or localized hives show up, contact the care team.

Thymosin Alpha-1: Common Questions

Into subcutaneous fat at one of four regions: the abdomen (keeping two inches clear of the navel), the front or outer thigh, the upper outer glute, or the fat pad behind the deltoid. The abdomen and thigh carry most doses for most patients because they are easy to see, easy to reach, and large enough to rotate within for weeks.

Subcutaneous. The needle goes into the fat layer just under the skin, not into muscle. A short insulin syringe held at a 45 to 90 degree angle is all it takes. There is no version of the PeRx protocol that calls for intramuscular administration.

The prescribed dose is 20 units, which is the 20 mark on a standard U-100 insulin syringe and equals 0.2 mL of solution. Draw to that line and stop. Your prescription label is the authority on your specific dose.

Because that is how the protocol is written: once daily on weekdays, with weekends off already built in. It is not a cycle break you are managing yourself, and it is not something to shuffle around for convenience. Five doses a week, then two days off, repeating.

No. Ta1 requires no cycling and is considered safe for continuous long-term use as prescribed. There is no washout period to schedule and no built-in stopping point. That is part of why building a rotation habit early pays off, since the schedule is meant to keep going.

No. They are different molecules from different branches of the thymosin family, used for different reasons. Thymosin Alpha-1 is a 28-amino-acid thymic peptide; TB-500 is a synthetic fragment of thymosin beta-4. Ta1 is the only thymosin PeRx sells on its own, and TB-500 is supplied only inside combination products. A protocol written for one says nothing useful about the other.

No. PeRx ships Thymosin Alpha-1 fully reconstituted and ready to use, so there is nothing to add and nothing to prepare. Store it refrigerated at 36-46°F, keep it upright, inspect that the solution is clear, then draw your 20 units and inject.

Rarely more than a pinch. Mild injection-site discomfort is the most commonly reported effect, and it usually traces back to cold solution or a fast plunger rather than to the peptide itself. Letting the drawn syringe warm briefly and injecting over several seconds handles most of it.

Inject it as soon as you remember that same day. If the day has already passed, skip it and resume on the next scheduled weekday. Do not double up to make up ground. One missed dose in a continuous protocol is not a setback worth correcting for.

A 5 mL vial at 5 mg/mL holds 25 mg. At 0.2 mL per dose, that is 25 weekday doses, which covers five working weeks. Keep it refrigerated between uses and inspect the solution each morning before you draw.

Transplant recipients and anyone on immunosuppressant medication should use caution, since Ta1 is an immune-modulating peptide and that runs counter to a treatment plan built on suppression. Raise it during screening.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to get started?

Pharmaceutical-grade Thymosin Alpha-1, prescribed by a licensed provider and shipped to your door fully reconstituted and ready to use.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.